Searching for the best healthcare options for your journey.
Explore MEDLATEC GenCare Premium, combining hereditary cancer risk assessment, genetic health screening, carrier screening for recessive disorders common in Vietnam, and SPOT-MAS 10 multi-cancer screening in one comprehensive package.
Est. duration | 0 - 1 hours |
Stay required | 0 - 1 days |
Recovery period | 0 - 0 weeks |
GenCare Premium is a comprehensive genetic and multi-cancer screening package offered by MEDLATEC in Vietnam.
The package combines hereditary cancer risk assessment, genetic testing for other health conditions, carrier screening for recessive genetic disorders common in Vietnam, and SPOT-MAS 10 blood-based multi-cancer screening.
By bringing together inherited genetic risk assessment and molecular cancer signal screening, GenCare Premium provides information that may support personalised preventive healthcare planning, reproductive health discussions, and further medical evaluation when appropriate.
GenCare Premium combines four complementary testing components.
Hereditary Cancer Risk Assessment – 145 Genes, 30 Conditions
This component analyses 145 genes associated with 30 hereditary cancer conditions.
It aims to identify inherited genetic variants that may be associated with increased susceptibility to certain cancers.
The results may help healthcare professionals discuss personalised screening recommendations, risk management strategies, and whether additional genetic counselling or family assessment is appropriate.
A hereditary cancer risk result does not indicate whether cancer is currently present.
Genetic Risk Assessment for Other Health Conditions – 34 Genes, 30 Conditions
This component examines 34 genes associated with 30 other health conditions included in MEDLATEC's genetic testing panel.
It provides additional information about selected inherited genetic factors that may be relevant to an individual's long-term health.
The clinical significance of each finding depends on the specific gene, variant classification, medical history, and available scientific evidence.
Carrier Screening for Recessive Genetic Disorders – 19 Genes, 18 Conditions
GenCare Premium includes carrier screening for 18 recessive genetic disorders covered by a 19-gene panel focused on conditions relevant to the Vietnamese population.
Individuals who carry a disease-causing variant for an autosomal recessive condition are often healthy and may not know they are carriers.
If both biological parents carry disease-causing variants in the same gene associated with an autosomal recessive condition, each pregnancy may have a 25% chance of resulting in an affected child.
This component may be particularly relevant to individuals or couples considering future family planning.
Carrier screening may help patients:
Understand carrier status for selected inherited disorders.
Identify findings relevant to reproductive planning.
Discuss whether partner testing may be appropriate.
Seek genetic counselling to understand potential risks to future children.
A negative carrier screening result does not eliminate all reproductive or genetic risks.
SPOT-MAS 10 Multi-Cancer Screening
GenCare Premium also includes SPOT-MAS 10, a blood-based molecular screening test designed to analyse biological signals associated with 10 cancer types.
The cancer types covered include:
Breast cancer
Lung cancer
Liver and biliary tract cancer
Stomach cancer
Colorectal cancer
Ovarian cancer
Pancreatic cancer
Esophageal cancer
Endometrial cancer
Head and neck cancers within the test's specified scope
SPOT-MAS 10 uses next-generation sequencing (NGS) and computational analysis to evaluate cancer-associated molecular signals in blood.
Unlike hereditary genetic testing, SPOT-MAS 10 examines biological signals that may be associated with an existing cancer.
However, SPOT-MAS 10 is a screening test, not a diagnostic test. An abnormal result requires further clinical assessment, and a negative result does not completely exclude cancer.
Comprehensive Genetic and Cancer Risk Assessment
GenCare Premium combines several testing approaches, providing information about hereditary cancer susceptibility, other genetic health conditions, reproductive carrier status, and molecular signals associated with selected cancers.
Extensive Hereditary Cancer Genetic Analysis
The 145-gene hereditary cancer panel covers 30 hereditary cancer conditions, offering a broader assessment than smaller genetic panels.
Supports Long-Term Preventive Healthcare Planning
Genetic findings may help healthcare professionals recommend appropriate clinical evaluation, personalised screening strategies, and additional genetic counselling where indicated.
Includes Reproductive Carrier Screening
The 19-gene carrier screening panel may provide useful information for individuals and couples planning to have children, particularly when discussing recessive genetic conditions relevant to the Vietnamese population.
Includes SPOT-MAS 10 Multi-Cancer Screening
The package includes a blood-based test that evaluates biological signals associated with 10 cancer types, providing an additional screening component alongside hereditary genetic risk assessment.
Provides Information Relevant to Family Health
Certain inherited genetic findings may also be relevant to biological relatives. Genetic counselling can help determine whether family members should consider further assessment.
GenCare Premium may be considered by individuals who:
Want to discuss a comprehensive genetic health assessment.
Have a personal or family history of cancer.
Have relatives diagnosed with cancer at relatively young ages.
Have a family history suggestive of hereditary genetic conditions.
Are planning to have children and wish to discuss carrier screening.
Want to explore inherited health risks as part of preventive healthcare planning.
Have been advised by a healthcare professional to consider expanded genetic testing.
The package is not necessarily appropriate for everyone. Test selection should be guided by personal medical history, family history, individual risk factors, and professional advice.
Step 1: Pre-Test Consultation
A healthcare professional reviews the patient's medical history, family history, screening goals, and suitability for the package.
Genetic counselling may be recommended before testing to explain the possible findings and their implications.
Step 2: Sample Collection
Biological samples are collected according to MEDLATEC's requirements for the genetic testing panels and SPOT-MAS 10.
Step 3: Laboratory Analysis
The laboratory performs the relevant genetic analyses and molecular cancer signal screening.
Step 4: Results
Results are generally expected in approximately 15 working days, subject to laboratory confirmation. Different components may have different reporting schedules.
Step 5: Results Interpretation and Follow-Up
A qualified healthcare professional reviews the findings and discusses whether additional screening, genetic counselling, partner testing, or diagnostic evaluation may be appropriate.
Hereditary Genetic Findings
A pathogenic or likely pathogenic inherited variant may indicate increased susceptibility to a particular condition. It does not mean the condition is currently present or will definitely develop.
A negative result does not eliminate all hereditary risks.
Carrier Screening Findings
Carrier status may be relevant to reproductive planning. Depending on the condition and inheritance pattern, testing a biological partner may be recommended.
SPOT-MAS 10 Screening Findings
An abnormal cancer screening result does not confirm cancer. Additional clinical investigation may be required.
A negative SPOT-MAS 10 result does not completely exclude cancer and should not replace established screening recommendations.
Package Name: GenCare Premium
Test Category: Comprehensive Genetic & Multi-Cancer Screening
Hereditary Cancer Assessment: 145 Genes / 30 Conditions
Other Genetic Health Conditions: 34 Genes / 30 Conditions
Recessive Disorder Carrier Screening: 19 Genes / 18 Conditions
Multi-Cancer Screening: SPOT-MAS 10
Cancer Types Screened by SPOT-MAS 10: 10
Expected Result Time: Approximately 15 Working Days
MediHub supports international patients travelling to Vietnam for healthcare services, including genetic testing, cancer screening, and preventive healthcare planning.
Beyond medical appointment coordination, MediHub provides assistance throughout the patient's healthcare journey.
Our support services may include:
Healthcare service and package consultation
Appointment scheduling and coordination with MEDLATEC
Pre-arrival guidance and preparation
Visa and travel assistance where required
Airport transfers and local transportation
Accommodation arrangements
Medical interpreter coordination
Assistance during medical appointments and testing
Medical results and follow-up coordination
Travel and tourism arrangements during the stay in Vietnam
From initial consultation and trip planning to medical appointments and post-visit follow-up, MediHub acts as a coordination point for international patients throughout their healthcare journey.
Looking for a comprehensive genetic and cancer screening package during your visit to Vietnam?
Contact MediHub for personalised assistance in planning your GenCare Premium testing journey.
Our team can help you understand the package components, coordinate appointments with MEDLATEC, prepare for your visit, and arrange travel-related support according to your schedule.
GenCare Premium combines hereditary genetic risk assessment, carrier screening, and molecular cancer signal screening. These components have different clinical purposes and limitations.
Hereditary genetic testing does not diagnose an existing cancer. Carrier screening does not determine whether an individual has cancer. SPOT-MAS 10 is not a definitive diagnostic test and should not replace guideline-recommended cancer screening methods.
A negative result does not eliminate all cancer, genetic, or reproductive risks.
Results should be interpreted by appropriately qualified healthcare professionals, with genetic counselling where indicated. Further clinical evaluation may be necessary depending on the findings.
Top experts performing this treatment
Expertise: Diagnosis and treatment of respiratory and pulmonary diseases , including asthma, COPD, pneumonia, bronchitis...
Expertise: Medical laboratory testing, clinical microbiology, and molecular biology Advanced laboratory techniques for e...
OncoSure Plus focuses on hereditary cancer risk across 145 genes and 30 conditions. GenCare Premium includes that assessment plus genetic testing for other health conditions, recessive disorder carrier screening, and SPOT-MAS 10 multi-cancer screening
The SPOT-MAS 10 component screens for biological signals associated with 10 cancer types, but it does not diagnose cancer. The hereditary genetic panels assess inherited susceptibility rather than detecting existing tumours.
Yes. The package includes a 19-gene panel covering 18 recessive genetic disorders relevant to the Vietnamese population. Results may help individuals or couples discuss reproductive risks and whether partner testing is appropriate.
Patients may be able to return home after sample collection and receive results remotely, subject to MEDLATEC's procedures. MediHub can help coordinate result delivery and follow-up arrangements.
Start Your Journey
100% Verified Hospital Data & JCI Standards
Best Price Guarantee for International Patients
Why MediHubVietNam
MediHubVietNam connects international patients with Vietnam’s leading hospitals, clinics, and specialists. Our role is to simplify your healthcare journey by helping you find the right provider, understand your options, and coordinate your appointment with confidence.
